University of Missouri reactor is first domestic supplier of I-131 in 30 years

Michael Walter | | Radiology Business | Economics
MURR reactor

The University of Missouri Research Reactor. Photo courtesy of the University of Missouri.

The University of Missouri Research Reactor (MURR) in Columbia has announced it is the first domestic supplier of Iodine-131 (I-131), a radioisotope used to diagnose and treat thyroid cancer and hyperthyroidism, in the last 30 years.

“Supplying I‑131 is part of a strategic initiative by the University of Missouri and MURR to address medical isotope shortages and further the University’s research mission,” David Robertson, executive director of MURR, said in a news release from the University of Missouri.

MURR, a part of the school for more than 50 years, is also a supplier of Therasphere, Quadramet and Lutathera, which was recently approved by the FDA to help treat pancreatic cancer patients, according to the news release.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Radiology group cancels hospital-based business to focus on outpatient center growth
RadNet has spent over $54M on acquisitions so far in 2024
Radiology provider Akumin breaks long radio silence after emerging from bankruptcy
Doc offices more than double use of nonphysicians for interpreting medical images
Radiology vendor Agfa to cut nearly $53M in costs as medical film business dwindles
Renewed optimism that radiologist-supported bill to ease prior authorization could pass by year’s end

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.